Sherko Kuemmel, Joerg Heil, Anna Rueland, Christine Seiberling, Hakima Harrach, Dorothea Schindowski, Juliane Lubitz, Karin Hellerhoff, Christine Ankel, Sven-Thomas Graßhoff, Petra Deuschle, Volker Hanf, Kerstin Belke, Peter Dall, Julia Dorn, Gabriele Kaltenecker, Thorsten Kuehn, Ulrike Beckmann, Jochem Potenberg, Jens-Uwe Blohmer, Athina Kostara, Elisabeth Breit, Johannes Holtschmidt, Eugen Traut, Mattea Reinisch
OBJECTIVE: This study aimed to investigate the feasibility and accuracy of non-radioactive TLN biopsy and TAD in routine clinical practice. BACKGROUND DATA: TAD involves TLN biopsy (TLNB) and sentinel lymph node biopsy and was recently introduced as a new standard for less invasive axillary staging in BC patients undergoing neoadjuvant systemic therapy (NST); however, clinical evidence is limited. METHODS: The SenTa study is a prospective registry study conducted at 50 centers...
November 1, 2022: Annals of Surgery